NB-4746 by Nura Bio for Amyotrophic Lateral Sclerosis: Likelihood of Approval

NB-4746 is under clinical development by Nura Bio and currently in Phase I for Amyotrophic Lateral Sclerosis.

California Psychedelic Decriminalisation Bill Clears Appropriations Committee with Amendments – Psychedelic Alpha

California’s psychedelic decriminalisation bill, SB-58, was passed with amendments by the Assembly Appropriations Committee. Its amended version will now head to the assembly floor for

September 1, 2023

The Importance of ‘Privacy and Security by Design’ in Healthcare

Chris Bowen, founder and CISO at ClearDATA In healthcare, sensitive data comes with great responsibility. For companies entrusted with managing and protecting patients’ personal information,

December 22, 2023

Higher Risk of Infant Death Tied to Dual Cannabis, Nicotine Use in Pregnancy

Use of cannabis and nicotine together during pregnancy was associated with higher risks for infant death and maternal and neonatal morbidity compared with no exposure

May 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.